Mackenzie Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,133
Closed -$202K 1726
2024
Q3
$202K Sell
7,133
-27,650
-79% -$713K ﹤0.01% 1389
2024
Q2
$665K Buy
34,783
+27,650
+388% +$706K ﹤0.01% 949
2024
Q1
$234K Hold
7,133
﹤0.01% 1280
2023
Q4
$236K Buy
+7,133
New +$202K ﹤0.01% 1260
2023
Q3
Sell
-7,133
Closed -$215K 1507
2023
Q2
$215K Buy
+7,133
New +$231K ﹤0.01% 1317
2022
Q4
Sell
-17,041
Closed -$612K 1483
2022
Q3
$612K Buy
+17,041
New +$600K ﹤0.01% 893
2019
Q1
Sell
-22,995
Closed -$459K 1251
2018
Q4
$459K Buy
+22,995
New +$532K ﹤0.01% 951
2018
Q2
Sell
-1,146,242
Closed -$16.3M 1023
2018
Q1
$16.3M Hold
1,146,242
0.04% 259
2017
Q4
$14.1M Hold
1,146,242
0.03% 302
2017
Q3
$20.4M Hold
1,146,242
0.11% 180
2017
Q2
$29.1M Buy
1,146,242
+404,500
+55% +$9.73M 0.16% 153
2017
Q1
$16.5M Buy
741,742
+675,842
+1,026% +$13M 0.1% 198
2016
Q4
$975K Buy
+65,900
New +$1.3M 0.01% 444

Other funds holding EVH

Mackenzie Financial's EVH Position: Q4 2024 in Review

Mackenzie Financial sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 7,133 shares — an estimated $202K sold.

Mackenzie Financial first reported a position in EVH in Q4 2016 and held it in 13 quarters. The position peaked at $29.1M in Q2 2017. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Mackenzie Financial reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Mackenzie Financial sold 7,133 Evolent Health shares in Q4 2024, an estimated $202K.
  • Mackenzie Financial first reported a position in Evolent Health in Q4 2016 and held it in 13 quarters.
  • Mackenzie Financial's Evolent Health position peaked at $29.1M in Q2 2017.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Mackenzie Financial's 13F filing for Q4 2024, filed 14 Feb 2025.